L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats

Nephrology

Volumn 11, Issue 4, 2006, Pages 313-320

  Boonsanit, Dolrudee ^a   Kanchanapangka, Sumolaya ^a   Buranakarl, Chollada ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Doxorubicin; L carnitine; Nephrotic syndrome; Oxidative stress; Renal function

Indexed keywords

CARNITINE; CATALASE; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY PLASMA FLOW; KIDNEY TUBULE; KIDNEY VASCULAR RESISTANCE; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VASODILATATION;

ANIMALS; CARNITINE; DOXORUBICIN; MALE; NEPHROTIC SYNDROME; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746129545     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00592.x     Document Type: Article

References (31)

1. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 1986; 24: 152-9.
2. Grond J, Weening JJ, vanGoor H, Elema JD. Application of puromycin aminonucleoside and adriamycin to induce chronic renal failure in the rat. Contrib. Nephrol. 1998; 60: 83-93.
3. Hall RL, Wilke WL, Fettman MJ. The progression of adriamycin induced nephrotic syndrome in rats and effect of captopril. Toxicol. Appl. Pharmacol. 1986; 82: 164-74.
4. Bertani T, Poggi A, Pozzni R, Delaini F. Adriamycin-induced nephrotic syndrome in rat: Sequence of pathology rat. Lab. Invest. 1982; 46: 16-23.
5. Milner LS, Wei SH, Houser MT. Amelioration of glomerular injury in doxorubicin hydrochloride nephrosis by dimethythiourea. J. Lab. Clin. Med. 1991; 118: 427-34.
6. Okasora T, Takikawa T, Utsunomiya Y et al. Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron 1992; 60: 199-203.
7. Wu SH, Yang YC, Wang ZM. Role of oxygen radicals in adriamycin-induced nephrosis. Chin. Med. J. (Engl.) 1990; 103: 283-9.
8. Kaslfi K, Israel M, Sweatman TW, Seshadri R, Cook GA. Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues. Biochem. Pharmacol. 1990; 40: 1441-8.
9. Shug AL. Protection from adriamycin-induced cardiomyopathy in rats. Z. Kardiol. 1987; 76: 46-52.
10. Sayed-Ahmed MM, Shaarawy S, Shouman SA, Osman AM. Reversal of doxorubicin-induced cardiac metabolic damage by 1-carnitine. Pharmacol. Res. 1999; 39: 289-95.
11. Kopple JD, Ding H, Letoha A et al. 1-carnitine ameliorates gentamicin-induced renal injury in rats. Nephrol. Dial. Transplant. 2002; 17: 2122-31.
12. Buranakarl C, Kitjtawonrat A, Pondeenana S et al. Comparison of dipyridamole and fosinopril on renal progression in nephrectomized rats. Nephrology 2003; 8: 80-91.
13. Brun CA. Acidosis rapid method for the determination of paraaminohippuric acid in kidney function tests. J. Lab. Clin. Med. 1951; 37: 955-8.
14. Young MK Jr, Raisz LG. An anthrone procedure for determination of inulin in biological fluids. Proc. Soc. Exp. Biol. Med. 1952; 80: 771-4.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall KJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissue thiobarbiture acid reaction. Anal. Biochem. 1979; 95: 531-8.
17. Beutler E, Duron O, Kelly BM. Improve method for the determination of blood glutathione. J. Lab. Clin. Med. 1963; 61: 882-8.
18. Aebi H. Catalase. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis. New York: Academic Press, 1983; 237-82.
19. Venkatesan N, Punithavathy D, Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br. J. Phamacol. 2000; 129: 231-4.
20. Malarkodi KP, Varalakshmi P. Lipid acid as a rescue agent for adriamycin-induced hyperlipidemic nephropathy in rats. Nutr. Res. 2003; 23: 539-48.
21. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV. Hyperlipidemic nephropathy induced by adriamicin: Effect melatonin administration. Nephron 1997; 76: 345-50.
22. Hong YM, Kim HS, Yoon H. Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine. Pediatr. Res. 2002; 51: 249-55.
23. Weening JJ, Rennke HG. Glomerular permeability and polynion in adriamycin nephrosis in the rats. Kidney Int. 1983; 24: 152-9.
24. Bristow MR, Billingham ME, Minobe WA, Masek MA, Daniels JR. Histamine and catecholamines mediate chronic cardiac and renal damage associated with adriamycin administration. Clin. Res. 1979; 27: 156.
25. O'Donnell MP, Michels L, Kasiske B, Raij L, Keane WF. Adriamycin-induced chronic proteinuria: A structural and functional study. J. Lab. Clin. Med. 1985; 106: 62-7.
26. Palomba D, Pes GM, Demontis MP, Varoni MV, Deiana L, Ananior V. Metabolic and renal effect of Laevo-carnitine and propionyl-carnitine in rats with subtotal nephrectomy. Pharmacol. Res. 1996; 34: 161-5.
27. Chang B, Nishikawa M, Sato E, Utsumi K, Inouc M. L-carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch. Biochem. Biophys. 2002; 405: 55-64.
28. Luo XP, Evrovsky Y, Cole D, Trines J, Benson LN, Lechotay DC. Doxorubicin-induced acute changes in cytotoxic aldehydes, anti-oxidant status and cardiac function in the rat. Biochim. Biophy. Acta 1997; 1360: 45-52.
29. Venkatesan N, Venkatesan P, Karthikeyan J, Venkatesan A. Protection of taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. Proc. Soc. Exp. Med. 1997; 215: 158-64.
30. Zima T, Tesar V, Stipek S et al. The influence cyclosporin on lipid peroxidation and superoxide dismutate adriamycin nephropathy in rats. Nephron 1997; 75: 464-8.
31. Luo X, Reichetzer B, Trines J, Benson TL, Lehotay DC. L-carnitine attenuates doxorubicin-induced lipid peroxidation in rats. Free Radic. Biol. Med. 1999; 26: 1158-65.